Hepatitis E Virus Infection in Pediatric Oncology
- PMID: 36598968
- DOI: 10.1097/MPH.0000000000002539
Hepatitis E Virus Infection in Pediatric Oncology
Abstract
Background: In the 2016 ESPGHAN recommendations on how to deal with hepatitis E virus infection in immunocompromised children, patients treated with chemotherapy were not specifically mentioned.
Observations: Two teenagers treated with chemotherapy for acute leukemia and medulloblastoma, respectively, were diagnosed with hepatic cytolysis. After numerous investigations hepatitis E was found, limiting the good progress of the chemotherapy treatment.
Conclusion: In the case of liver cytolysis in immunocompromised children treated with chemotherapy, hepatitis E virus infection has to be promptly diagnosed.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Colson P, Coze C. Transfusion-associated hepatitis E, France. Emerg Infect Dis. 2007;13:647.
-
- Motte A, Roquelaure B, Galambrun C, et al. Hepatitis E in three immunocompromized children in southeastern France. J Clin Virol. 2012;53:162–166.
-
- Blasco Perrin H, Abravanel F, Péron JM. Hepatitis E Virus in France, recent epidemiological and clinical data. Hépato Gastro. 2015;22:795–802.
-
- Kamar N, Sleves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811–817.
-
- Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370:1111–1120.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
